online-thrilokyavijaya-book-pdf-version-1

f;jk fldgi
uQ,dY%
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
Pertwee R.G. 1988. The central neuropharmacology of psychotropic
cannabinoids. Pharmacology & Therapeutics 36:189–261.
Pertwee R.G. 2008. The diverse CB 1
and CB 2
receptor pharmacology of
three plant cannabinoids: Δ 9 -tetrahydrocannabinol, cannabidiol and Δ 9 -
tetrahydrocannabivarin. British Journal of Pharmacology 153:199–215.
Pertwee R.G. 1972. The ring test: a quantitative method for assessing the
'cataleptic' effect of cannabis in mice. British Journal of Pharmacology
46:753–763.
Piomelli D. & O. Sasso. 2014. Peripheral gating of pain signals by endogenous
lipid mediators. Nature Neuroscience 17:164–174.
Piomelli D. 2013. A fatty gut feeling. Trends in Endocrinology and Metabolism
24:332–341.
Plasse T.F., R.W. Gorter, S.H. Krasnow, M.Lane, Shepard K.V. & R.G.
Wadleigh. 1991. Recent clinical experience with dronabinol. Pharmacology
Biochemistry and Behavior 40(3):695–700.
Podolsky S., Pattavina C.G. & M.A. Amaral. 1971. Effect of marijuana in the
glucosetolerance test. Annals of New York Academy of Sciences 191:54–60.
Porter B.E. & C. Jacobson. 2013. Report of a parent survey of cannabidiolenriched
cannabis use in pediatric treatment-resistant epilepsy. Epilepsy
Behavior 29:574–577.
Rajurkar N.S. & B.M. Pardeshi. 1997. Analysis of some herbal plants from
India used in the control of diabetes mellitus by NAA and AAS techniques.
Applied Radiation and Isotopes 48(8):1059–1062.
Rana T.S. & B. Datt. 1997. Ethnobotanical observation among Jaunsar-Bawar,
Dehra Dun (J.P.), India. International Journal of Pharmacology 35(5):371–374.
Rao R.R. 1981. Ethnobotany of Meghalaya: Medicinal plants used by Khasi
and Garo tribes. Economical Botany 35(1):4–9.
Reynolds J.R. 1890. Therapeutic uses and toxic effects of Cannabis indica,
Lancet 1:637-638.
Roitman P., Mechoulam R., Cooper-Kazaz R. & A. Shalev. 2014. Preliminary,
open-label, pilot study of add-on oral δ(9)-tetrahydrocannabinol in chronic
post-traumatic stress disorder. Clinical Drug Investigation 34:587–591.
Rosenkrantz H. & D.W. Hayden. 1979. Acute and subacute inhalation toxicity
of Turkish marihuana, cannabichromene, and cannabidiol in rats. Toxicology
Applied Pharmacology 48(3):375–86.
Ross S. & M.A. Elsohly. 1995. Constituents of Cannabis sativa (L). XXVIII
- A review of the natural constituents: 1980–1994. Zagazig Journal of
Pharmaceutical Sciences, 4:1–10.
Russo E.B. & G.W. Guy. 2006. A tale of two cannabinoids: the therapeutic
rationale for combining tetrahydrocannabinol and cannabidiol. Medical
Hypotheses 66:234–246.
345